Dosage and administration
chew 2-3 tablets as symptoms occur, or as directed by a doctor
chew 2-3 tablets as symptoms occur, or as directed by a doctor
ULTRA Strength Antacid Rolaids Mint 72 Chewable Tablets
Drug Facts
(in each tablet)
Calcium carbonate USP 1000 mg
Magnesium hydroxide USP 200 mg
Antacid
relieves:
now taking a prescription drug. Antacids may interact with certain prescription drugs.
each tablet contains: calcium 400 mg, magnesium 8 5 mg
dextrose, flavor, magnesium stearate, silicon dioxide, stearic acid, sucralose, sucrose (309-055)
As a daily source of calcium and magnesium, chew 2 tablets twice daily.
| Supplement Facts Serving Size: 2 Tablets, Servings Per Container: 36, Amount Per Serving: Calories 12, Total Carb 2 g (<1% DV*), Sugars 2 g (†DV), Calcium 800 mg (54% DV), Magnesium 170 mg (29% DV). *Percent Daily Values (DV) are based on a 2,000 calories diet. †Daily Value not established. |
sucrose, dextrose, stearic acid, magnesium stearate, silicon dioxide, flavor, sucralose
ULTRA STRENGTH
Rolaids®
ANTACID
Rapid Relief of:
Heartburn
Acid Indigestion
72 Chewable Tablets
Mint
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1438105 | calcium carbonate 1000 MG / magnesium hydroxide 200 MG Chewable Tablet | PSN | 8 |
| 1438107 | Rolaids ULTRA 1000 MG / 200 MG Chewable Tablet, Reformulated Aug 2006 | PSN | 8 |
| 1438107 | calcium carbonate 1000 MG / magnesium hydroxide 200 MG Chewable Tablet [Rolaids Reformulated Aug 2006] | SBD | 8 |
| 1438105 | calcium carbonate 1000 MG / magnesium hydroxide 200 MG Chewable Tablet | SCD | 8 |
| 1438107 | Rolaids Ultra (calcium carbonate 1000 MG / magnesium hydroxide 200 MG) Chewable Tablet, Reformulated Aug 2006 | SY | 8 |
| Class | Version | Type | Effective |
|---|---|---|---|
| CALCIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0041167100318 | GTIN-13: 0041167100318 EAN-13: 0041167100318 GTIN-12: 041167100318 UPC-A: 041167100318 GTIN storage (14 digits): 00041167100318 | rolaids-ultra-strength-tablets-mint-01.jpg |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41167-1003-1 | Rolaids Ultra Strength Mint | 72 in 1 BOTTLE, PLASTIC | TABLET, CHEWABLE | 72 | 8 | |
| 41167-1003-2 | Rolaids Ultra Strength Mint | 87 in 1 BOTTLE, PLASTIC | TABLET, CHEWABLE | 87 | 8 | |
| 41167-1003-3 | Rolaids Ultra Strength Mint | 160 in 1 BOTTLE, PLASTIC | TABLET, CHEWABLE | 160 | 8 | |
| 41167-1003-4 | Rolaids Ultra Strength Mint | 10 in 1 PACKAGE | TABLET, CHEWABLE | 10 | 8 | |
| 41167-1003-5 | Rolaids Ultra Strength Mint | 10 in 1 PACKAGE | TABLET, CHEWABLE | 10 | 8 | |
| 41167-1003-5 | Rolaids Ultra Strength Mint | 3 in 1 CELLO PACK | TABLET, CHEWABLE | 3 | 8 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM CARBONATE | ACTIVE INGREDIENT | H0G9379FGK | 1 | |
| MAGNESIUM HYDROXIDE | ACTIVE INGREDIENT | NBZ3QY004S | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | 1 | |
| DEXTROSE | INACTIVE INGREDIENT | IY9XDZ35W2 | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| SUCRALOSE | INACTIVE INGREDIENT | 96K6UQ3ZD4 | 1 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 41167-1003 | 41167-1003-4, 41167-1003-1, 41167-1003-2, 41167-1003-3, 41167-1003-5 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CALCIUM CARBONATE | H0G9379FGK | ACTIB |
| MAGNESIUM HYDROXIDE | NBZ3QY004S | ACTIB |
| DEXTROSE | IY9XDZ35W2 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
| SUCROSE | C151H8M554 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET, CHEWABLE / ORAL | 1286 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, CHEWABLE / ORAL | 28 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET, CHEWABLE / ORAL | 1286 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET, CHEWABLE / ORAL | 1286 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET, CHEWABLE / ORAL | 1286 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, CHEWABLE / ORAL | 28 mg | ||
| STEARIC ACID | STEARIC ACID | 4ELV7Z65AP | TABLET, CHEWABLE / ORAL | 180 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, CHEWABLE / ORAL | 28 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, CHEWABLE / ORAL | 28 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET, CHEWABLE / ORAL | 1286 mg | ||
| SILICON DIOXIDE | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, CHEWABLE / ORAL | 28 mg | ||
| DEXTROSE | DEXTROSE | IY9XDZ35W2 | TABLET, CHEWABLE / ORAL | 1286 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| SUCRALOSE | SUCRALOSE | 96K6UQ3ZD4 | TABLET, CHEWABLE / ORAL | 28 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rolaids Ultra Strength Mint | CALCIUM CARBONATE AND MAGNESIUM HYDROXIDE | Chattem, Inc. | 8806c912-ab83-4f45-ac78-e826bb3143d4 | 2026-01-14 | Warnings | 41167-1003-3 41167-1003-4 41167-1003-2 41167-1003-1 41167-1003-5 41167-1003 41167100304 41167100305 41167100302 41167100301 41167100303 5a3751c1-7f0f-4dcf-93e9-8e0cff9116b1 8806c912-ab83-4f45-ac78-e826bb3143d4 |
Adverse event summaries are temporarily unavailable. Other product information remains available.